Skip to main content

BvCW Poll Finds 88% Support For Legal Cannabis Plant Sales In Germany

|
Cannabis-plant-clones-genetics-strains-starts-min

The German Cannabis Business Association (BvCW) recently conducted a poll asking the question “Should the commercial trade in cannabis cuttings be legal for people over 18, in addition to distribution by cultivation associations?” (translated from German to English).

According to the BvCW poll, which was conducted from September 16, 2024 – September 23, 2024, as part of the organization’s newsletter, 88% of respondents selected ‘yes’, 2% selected ‘partly’, 3% selected ‘rather no’, 5% selected ‘no’, and 2% selected ‘don’t know.’

Starting on April 1st, 2024, adults aged 18 or older can cultivate up to three plants in Germany in their private residences. In order for home cultivators to start their gardens, they first need to acquire cannabis genetics in the form of cannabis seeds or cuttings/clones.

Limiting home cultivators in Germany to only seeds makes no rational sense being that the seed will eventually turn into a small plant anyway. Cannabis cuttings/clones provide some unique advantages over seeds that many cultivators prefer, including speeding up the cultivation process. Prohibiting them serves no purpose other than to perpetuate the illogical policies of Germany’s past.

A recent YouGov poll in Germany found that 7% of poll participants indicated that they had already purchased cannabis seeds or cuttings/clones since legalization took effect. In addition to the 7% of poll participants indicating that they had already purchased cannabis genetics for their home gardens, another 11% of poll participants responded that they plan to purchase cannabis genetics in the future.

Home cannabis cultivation by adults for recreational purposes is also legal in Uruguay, Canada, Malta, Luxembourg, South Africa, and in many states in the U.S. Major court decisions in other nations also provide some level of protection for cultivating personal amounts of cannabis.



© 2024 THE TALMAN GROUP. ALL RIGHTS RESERVED.